Navigation Links
PharMEDium Applauds Passage of Legislation to Strengthen Oversight of the Compounding Industry
Date:11/18/2013

WASHINGTON, Nov. 18, 2013 /PRNewswire/ -- PharMEDium congratulates Congress for coming together in a bipartisan fashion to reform the existing patchwork of compounding regulations. One year after the most deadly drug contamination incident in U.S. history, the Senate approved by voice vote the House-passed legislation to overhaul the way compounding is regulated. This process began many months ago and PharMEDium would like to applaud the determination and leadership of the Members of the Senate H.E.L.P. Committee and the House Energy and Commerce committee and their dedicated staffs in strengthening the oversight of the compounding industry.

The Drug Quality and Security Act will finally instill clarity and certainty into the oversight of compounding facilities, ensuring that large-scale sterile compounding operations that conduct interstate commerce are subject to appropriate federal oversight. This will result in a significant advance in the integrity of customized, compounded sterile preparations administered to millions of patients.

PharMEDium, the nation's leading provider of sterile admixture preparations for hospitals across the country, supports the establishment of a new category for "outsourcing facilities" that are registered with the U.S. Food and Drug Administration (FDA), are held to rigorous manufacturing-like standards, and are subject to routine FDA inspections. Although PharMEDium would have preferred mandatory FDA registration for large-scale sterile compounding operations that ship across state lines, we believe that effective communication between state and federal authorities will have the same effect.

PharMEDium has long advocated for clearer FDA authority and stronger oversight and we look forward to working with the Agency and other policymakers as they implement this landmark legislation. We believe that if implemented swiftly and fully, the Drug Quality and Security Act will help prevent another national disaster like last year's devastating fungal meningitis outbreak.

Who we are: PharMEDium is the nation's leading provider of hospital pharmacy-outsourced, sterile admixture services with centers in four states and thousands of acute care hospital customers nationwide. Our qualified personnel and state-of-the-art centers are registered with the FDA, licensed by the states, and governed by our own rigorous quality standards. We begin the compounding process with sterile FDA-approved finished drugs from FDA-approved drug manufacturers. It is our mission to be the preeminent provider of choice for hospital customers and to attain the highest degree of integrity in the compounding of sterile preparations.


'/>"/>
SOURCE PharMEDium
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
2. PharMEDium Encourages Swift Action to Strengthen Federal Oversight of Advanced Sterile Compounding
3. PharMEDium Supports Draft Legislation, Efforts to Strengthen Oversight of the Compounding Industry
4. CHPA Applauds Alabama Senates Passage of Anti-Meth Bill
5. CHPA Applauds Alabamas Adoption Of HB 363
6. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
7. CHPA Applauds Arizonas Adoption Of HB 2263
8. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
9. Obesity Care Continuum (OCC) Applauds FDA for Approval of New Obesity Drug
10. Novation Applauds FDAs Unique Device Identification Rule
11. American Academy of Pain Medicine Applauds FDA Action to Enhance Patient Safety on Prescribing Opioids; Offers AAPM Safe Opioid Prescribing Course as Educational Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... -- Astute Medical, Inc., developer of biomarkers for better healthcare, ... the 2017 National Kidney Foundation (NKF) Spring Clinical ... 22. Physicians will present data on two biomarkers, ... acute kidney injury (AKI) during the management of patients ... Elevated levels of TIMP-2 and IGFBP-7 have been shown ...
(Date:4/18/2017)... , April 18, 2017  Spero Therapeutics, LLC, a ... treatment of bacterial infections, will present preclinical data supporting ... of multidrug resistant (MDR) Gram-negative infections at the 27th ... April 22-25, 2017 in Vienna, Austria ... ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke ... its ANCD BRAIN device as the product advances towards regulatory and clinical phases. ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura ... the achievement of Cisco Select certification and SMB specialization. Altura is now ... , In earning the Select Certification, Altura fulfilled the training and exam ...
(Date:4/22/2017)... ... April 22, 2017 , ... ... consumers can save an average of 70% when buying medication online from Canadian ... are available when purchasing from other countries. The report (chart below) compares U.S. ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article in ... teeth, which reveal a great deal about prehistoric ice-age dental practitioners and their primitive ... been used to remove decayed dental matter, and that teeth were then filled with ...
Breaking Medicine News(10 mins):